Fred Hutch is proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans.
Read the Know your Rights: Workplace Discrimination is Illegal Poster.
Join us for Science Says on Wednesday, October 12, to hear from scientists and clinicians who are shaping groundbreaking treatment approaches as unique as the people who need them.
Every cancer is different, from its molecular makeup to the supportive microenvironment it creates. Precision oncology seeks to understand the seemingly infinite factors that distinguish each person’s disease and use that knowledge to personalize risk-reduction and treatment strategies. Fred Hutchinson Cancer Center is applying our research expertise in both immunotherapy and cellular biology to advance this rapidly evolving field — an endeavor that has been accelerated by a recent $78 million gift to establish the Stuart and Molly Sloan Precision Oncology Institute and plan for the construction of a new research building on our South Lake Union campus named in their honor.
Our Science Says panelists will discuss precision oncology’s potential for personalizing treatments to each person living with cancer, how it could revolutionize risk-reduction strategies, and what it will take to design and build a robust data science infrastructure to support it. Be sure to bring your questions!
Date: Wednesday October 12, 2022
Time: 10 - 11 a.m. PDT
Location: Virtual event